Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune activation.
Conjugate vaccines are composed of bacterial polysaccharide antigens covalently linked to protein carriers, enabling T cell-dependent immune responses that induce high-affinity antibodies and ...
AZoLifeSciences on MSN
Microneedle patches may unlock safer, localized cancer immunotherapy
This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized treatment and immune activation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback